Effect of Vortioxetine on Cognitive Impairment in Patients With Major Depressive Disorder: A Systematic Review and Meta-analysis of Randomized Controlled Trials

BACKGROUND: Dementia and depression are increasingly common worldwide, and their effective control could ease the burden on economies, public health systems, and support networks. Vortioxetine is a new antidepressant with multipharmacologic actions that elevate the concentration of serotonin and mod...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, I-Chen, Chang, Tsui-San, Chen, Chiehfeng, Sung, Jia-Ying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Regular Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9743961/
https://www.ncbi.nlm.nih.gov/pubmed/35981958
http://dx.doi.org/10.1093/ijnp/pyac054

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9743961/
https://www.ncbi.nlm.nih.gov/pubmed/35981958
http://dx.doi.org/10.1093/ijnp/pyac054

Ejemplares similares